HIGHLIGHTS
- who: Yi-Ling Cheng from the United States Technical University of have published the article: Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis, in the Journal: (JOURNAL)
- what: The experiments were repeated two or three times with similar results, data from a single experiment was presented. sera could interfere with DENV infection, the neutralizing ability of sera from COVID-19 patient against DENV infection was tested by an FRNT assay. The authors found a significant increase in antibody binding to SARS-CoV-2 trimeric spike and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.